Abstract
Rationale: The combination of lumacaftor (LUM) and ivacaftor (IVA) is an approved CFTR (cystic fibrosis [CF] transmembrane conductance regulator) modu......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
